Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-441-5 | CAS number: 83121-18-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 6 October 1983 to 11 November 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- - Principle of test:
The purpose of this acute intraperitoneal toxicity (LD50) study was to assess the toxicity of CME 134 when administered to rats by single intraperitoneal injection, followed by an observation period of 14 days. - GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 1-(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorobenzoyl)urea
- EC Number:
- 617-441-5
- Cas Number:
- 83121-18-0
- Molecular formula:
- C14 H6 Cl2 F4 N2 O2
- IUPAC Name:
- 1-(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorobenzoyl)urea
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: KFM: Wistar rat
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm Madoerin AG, CH 4414 Fuellinsdorf/Switzerland
- Age at study initiation: males: 7 weeks, females: 9 weeks
- Weight at study initiation: males: 166 - 243 g, females: 160 - 196 g
- Housing: animals were housed in groups of 5 in makrolon type-3 cages with wire mesh lids
- Diet: ad libitum, pelleted standard Kliba 343, rat maintenance diet (Klingentalmuehle AG, CH 4303 Kaiseraugst/Switzerland)
- Water: ad libitum, tap water
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 45-65
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- polyethylene glycol
- Details on exposure:
- The test substance dilution was intraperitoneally injected with a sterile needle and syringe into the abdominal cavity through the ventral abdominal wall in the inguinal region.
- Doses:
- Volume/kg body weight:
10 mL at 300 mg/kg bw
10 mL at 500 mg/kg bw
10 mL at 800 mg/kg bw
10 mL at 1200 mg/kg bw
10 mL at 2000 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 and 21 days
- Frequency of observations and weighing: Mortality was confirmed and recorded 5 times during test day 1 and daily on test days 2 to 15, respectively 22 in the rats of the 1200 and 2000 mg/kg bw groups.
Each animal had an examination for changes in appearence and behavior 5 times during day 1, and daily during days 2 to 15, respectively 22 in the rats of the 1200 and 2000 mg/kg bw groups.
Body weights were recorded on test days 1, 8 and 15, respectively 22 in the rats of the 1200 and 2000 mg/kg bw groups.
- Necropsy of survivors performed: yes - Statistics:
- The LOGIT Model could not be applied to the observed rates of death. The LD50 was estimated without use of a statistical model.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- The following death rates were observed:
10% at 300 mg/kg,
30% at 500 mg/kg,
20% at 800 mg/kg,
0% at 1200 mg/kg,
20% at 2000 mg/kg - Clinical signs:
- The following symptoms were observed:
15-day observation period:
300, 500 and 800 mg/kg bw: sedation, dyspnea, ataxia, curved body position, ruffled fur. Signs were resolved in surviving rats within 6 days (300 mg/kg bw), 7 days (500 mg/kg bw) or 11 days (800 mg/kg bw).
22-day observation period:
1200 mg/kg, males: sedation, dyspnea, ataxia, ventral and curved body position, ruffled fur. The surviving rats had recovered within 12 observation days.
1200 mg/kg, females: sedation, dyspnea, ataxia, curved body position, diarrhea, weight loss, ruffled fur. The surviving rats had not completely recovered at termination of the observation period.
2000 mg/kg, males: sedation, dyspnea, ataxia, ventral- and curved body position, ruffled fur. The surviving rats had recovered within 12 observation days.
2000 mg/kg, females: sedation, dyspnea, ataxia, curved body position, diarrhea, weight loss, ruffled fur. The surviving rats had not completely recovered at termination of the observation period. - Body weight:
- 500 mg/kg bw, males: loss of body weight between Day 1 and 8.
2000 mg/kg bw, males: loss of body weight between Day 1 and 8.
1200 mg/kg bw, females: loss of body weight between Day 1 and 15.
2000 mg/kg bw, females: loss of body weight between Day 1 and 15. - Gross pathology:
- In several rats, remainders of the test substance were found in the abdominal cavity. These remainders were found posterior to sternum in most rats. Peritonitis characterized by adhesions of liver to diaphragm, of liver lobes, and/or of intestinal loops was seen in all rats. The abdominal organs were covered by grey-white coatings.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.